Valuation: Microba Life Sciences Limited

Market Cap 34.42M 24.31M 21.03M 19.64M 18.01M 33.88M 2.31B 230M 90.43M 1.16B 91.29M 89.29M 3.83B P/E 2026 *
-1.92x
P/E 2027 * -5.33x
Enterprise Value 26.42M 18.66M 16.14M 15.07M 13.83M 26.01M 1.78B 177M 69.41M 890M 70.07M 68.54M 2.94B EV / Sales 2026 *
1.79x
EV / Sales 2027 * 1.37x
Free-Float
72.61%
Yield 2026 *
-
Yield 2027 * -
1 week+6.67%
1 month+17.07%
3 months-40.00%
6 months-47.83%
Current year-36.84%
1 week 0.05
Extreme 0.046
0.05
1 month 0.04
Extreme 0.037
0.05
Current year 0.04
Extreme 0.036
0.1
1 year 0.04
Extreme 0.036
0.1
3 years 0.04
Extreme 0.036
0.4
5 years 0.04
Extreme 0.036
0.45
10 years 0.04
Extreme 0.036
0.45
Manager TitleAgeSince
Chief Executive Officer - 2021-06-30
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - 2023-12-31
Director TitleAgeSince
Director/Board Member - 2017-01-30
Director/Board Member - -
Chairman - -
Date Insider Type Main position Quantity % Market Cap.
11/19/24 Buy

Chairman

100,000 0.0223%
11/19/24 Buy

Chairman

100,000 0.0223%
11/19/24 Buy

Director

200,000 0.0447%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+6.67%-46.67%-87.69% 24.31M
+21.37%+20.29%+111.98%+516.46% 46.43B
+0.83%+3.22%+20.06%+47.61% 25.88B
+0.67%+2.56%-18.72%-34.64% 7.76B
+6.20%+13.49%+35.65%+129.72% 5.69B
+0.95%+2.62%+21.17%+65.24% 3.39B
+10.76%+18.38%-26.68%+1,226.68% 2.3B
+6.49%+8.37%+185.69%+11.81% 2.13B
+11.67%+10.56%+32.06%+23.61% 2.02B
+3.35%+4.36%-4.07%-56.01% 1.99B
Average +6.23%+8.28%+31.05%+184.28% 9.76B
Weighted average by Cap. +11.54%+12.42%+63.89%+293.79%

Financials

2026 *2027 *
Net sales 14.77M 10.43M 9.03M 8.43M 7.73M 14.54M 993M 98.89M 38.81M 498M 39.18M 38.33M 1.65B 19.67M 13.89M 12.02M 11.22M 10.29M 19.36M 1.32B 132M 51.68M 663M 52.17M 51.03M 2.19B
Net income -17.2M -12.15M -10.51M -9.81M -9M -16.93M -1.16B -115M -45.19M -579M -45.62M -44.62M -1.92B -6.8M -4.8M -4.15M -3.88M -3.56M -6.69M -457M -45.52M -17.86M -229M -18.03M -17.64M -757M
Net Debt -8M -5.65M -4.89M -4.56M -4.19M -7.87M -538M -53.55M -21.02M -270M -21.22M -20.75M -891M -7.42M -5.24M -4.53M -4.23M -3.88M -7.3M -499M -49.66M -19.49M -250M -19.68M -19.25M -826M
Logo Microba Life Sciences Limited
Microba Life Sciences Limited is an Australia-based precision microbiome company. The Company is engaged in the discovery and development of therapeutics for chronic diseases and delivering gut microbiome testing services globally to researchers, clinicians, and consumers. It offers various platforms, such as Analysis, Discovery, and Therapeutic. Its Analysis platform is an end-to-end solution for microbiome analysis. Using advanced metagenomic sequencing technology and proprietary bioinformatic tools, it provides precise and comprehensive measurement of the human gut microbiome. Its Discovery Platform is a global databank for microbiome discovery and develops new health solutions from the gut microbiome. Its Therapeutic platform is a repeatable platform for microbial therapeutic leads. Its Diagnostic testing products are MetaXplore and MetaPanel. MetaXplore offers a comprehensive gastrointestinal testing solution. MetaPanel is an advanced gastrointestinal pathogen detection panel.
Employees
-
Date Price Change Volume
26-08-10 A$0.0480 0.00% 12,478
26-08-07 A$0.0480 -2.04% 48,806
26-08-06 A$0.0490 +4.26% 49,693
26-08-05 A$0.0470 -6.00% 7,311
26-08-04 A$0.0500 +11.11% 491,777
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0480AUD
Average target price
0.1182AUD
Spread / Average Target
+146.29%

Quarterly revenue - Rate of surprise